Rapid RV/LV vs Viz CTP
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your primary need is a highly specialized, rapid, and consistent assessment of pulmonary embolism severity. This tool excels at automatically measuring right and left ventricle ratios from CTPA scans, providing quick, objective data to aid in immediate clinical decision-making and reduce variability in PE severity assessment.
View Rapid RV/LV →Choose Viz CTP if…
Choose Viz CTP if you require a comprehensive, AI-powered platform for detecting a wide array of diseases and coordinating care across multiple specialties. Its strength lies in leveraging over 50 FDA-cleared algorithms for various conditions, providing real-time mobile access to high-fidelity imaging, and streamlining communication and workflows for faster diagnosis and treatment across your institution.
View Viz CTP →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | Viz CTP |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Subscription model |
| Deployment | On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall. | Cloud-native solution, integrates with PACS and EHRs. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz CTPViz CTP (Tool B) emphasizes real-time mobile access, a DICOM viewer with 3D manipulation, and an intelligent care coordination and communication platform, suggesting a highly flexible and integrated user experience. Its cloud-native deployment further enhances accessibility and ease of use across various clinical settings. Rapid RV/LV (Tool A) focuses on rapid analysis and clear annotations but lacks the broader workflow and mobile accessibility features of Tool B.
Clinical Value
Viz CTPViz CTP (Tool B) offers significantly broader clinical value with over 50 FDA-cleared algorithms for disease detection and streamlined workflows across numerous conditions, including LVO, ICH, and motion artifact correction. Rapid RV/LV (Tool A) provides valuable, FDA-cleared AI for a specific use caseu2014pulmonary embolism severity assessmentu2014but its scope is narrower compared to Tool B's extensive capabilities for faster diagnosis and treatment across a wider range of diseases.
Pricing & Value
Viz CTPViz CTP (Tool B) provides a more transparent pricing model, indicating a subscription based on the number of algorithms used and the size of the population served, which allows potential customers to better understand cost drivers. Rapid RV/LV (Tool A) offers no public pricing details, requiring direct vendor contact, which makes it harder to assess its value proposition upfront.
Enterprise Readiness
Viz CTPBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, establishing a strong foundation for enterprise use. However, Viz CTP (Tool B)'s cloud-native deployment and explicit integration with PACS and EHRs suggest a more modern, scalable, and potentially easier integration into complex hospital IT infrastructures, which is often a key consideration for enterprise solutions.
Innovation
Viz CTPViz CTP (Tool B) demonstrates broader innovation as a 'pioneer' with over 50 FDA-cleared algorithms, integrating AI with real-time mobile access, 3D manipulation, intelligent care coordination, and AI-powered motion artifact correction. While Rapid RV/LV (Tool A) offers innovative AI for PE assessment, Tool B's comprehensive approach to transforming clinical workflows across multiple diseases represents a more extensive and pioneering innovation in the healthcare AI space.
Support & Docs
Viz CTPBoth companies offer 24/7/365 customer support via phone and email. However, Viz.ai (Tool B) provides a more structured and extensive set of support resources, including a comprehensive Help Center with tutorials, Viz Academy for clinical education, and a transparent Trust Center for security and privacy documentation. RapidAI (Tool A) also offers FAQs and resources like webinars, but Viz.ai's offerings appear more comprehensive for self-service and compliance transparency.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | Viz CTP |
|---|---|---|
| Tool Name | Rapid RV/LV | Viz CTP |
| Company | RapidAI (formerly iSchemaView) | Viz.ai |
| Tagline | AI-powered rapid assessment of pulmonary embolism severity. | AI-powered disease detection and intelligent care coordination |
| Primary Function | Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. | AI-powered disease detection and intelligent care coordination, leveraging over 50 FDA-cleared algorithms to analyze medical imaging and streamline clinical workflows for faster diagnosis and treatment. |
| Key Features | AI-powered analysis of CTPA images, Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio, Annotated images showing ventricular measurements, Rapid results (within minutes of scan), Reduces inter-rater variability, Integration with Rapid PE solution, Triage and notification capabilities (as part of the broader Rapid platform) | AI-powered disease detection (50+ FDA-cleared algorithms), Real-time, mobile access to high-fidelity imaging (DICOM viewer, 3D manipulation), Intelligent care coordination and communication platform (HIPAA-compliant messaging), Automated image analysis and interpretation (e.g., CT perfusion maps, LVO detection), Prioritized worklists, EHR integration, AI-powered motion artifact correction for CTP, Automated measurements (e.g., ICH volume, subdural thickness/midline shift) |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and Viz CTP.